Search research articles
Contact Us
Filters
Showing results (121-130 of 204) with videos related to
Page
of 21
Sort By:
International Journal of Laboratory Hematology
|
March 5, 2023
Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders
Marco Pizzi, Marta Sbaraglia, Luca Dal Santo, et al.
European Journal of Haematology
|
January 11, 2021
Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: A word of caution
Marco Pizzi, Claudio Agostinelli, Luisa Santoro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2007
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis
Isabella Dell'Aica, Raffaele Niero, Francesco Piazza, et al.
Oncotarget
|
January 5, 2018
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
Andrea Visentin, Silvia Imbergamo, Federica Frezzato, et al.
Biomarker Research
|
April 10, 2026
Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis
Francesco Angotzi, Arianna Bevilacqua, Andrea Serafin, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
British Journal of Haematology
|
May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Frontiers in Oncology
|
January 29, 2026
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience
Mattia D'Antiga, Andrea Serafin, Francesco Angotzi, et al.
BMC Cancer
|
October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Hematological Oncology
|
September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature
Andrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 204) with videos related to
Sort By:
Page
of 21
International Journal of Laboratory Hematology
|
March 5, 2023
Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders
Marco Pizzi, Marta Sbaraglia, Luca Dal Santo, et al.
European Journal of Haematology
|
January 11, 2021
Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: A word of caution
Marco Pizzi, Claudio Agostinelli, Luisa Santoro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2007
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis
Isabella Dell'Aica, Raffaele Niero, Francesco Piazza, et al.
Oncotarget
|
January 5, 2018
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
Andrea Visentin, Silvia Imbergamo, Federica Frezzato, et al.
Biomarker Research
|
April 10, 2026
Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis
Francesco Angotzi, Arianna Bevilacqua, Andrea Serafin, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
British Journal of Haematology
|
May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Frontiers in Oncology
|
January 29, 2026
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience
Mattia D'Antiga, Andrea Serafin, Francesco Angotzi, et al.
BMC Cancer
|
October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Hematological Oncology
|
September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature
Andrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
Page
of 21